Newsroom | 4674 results

DENVER--(BUSINESS WIRE)--Virta Health, a leader in diabetes reversal and sustainable weight loss with a nutrition-first approach, today released a report showing that people can maintain weight loss after stopping GLP-1 medication with the right guidance and lifestyle support—challenging the belief that weight regain is inevitable. Critically, the survey found those who tapered off GLP-1s under medical guidance were eight times more likely to continue losing weight after stopping (56%), compare...

BETHESDA, Md. & PROVIDENCE, R.I.--(BUSINESS WIRE)--LucyRx, an independent, next-generation pharmacy benefits manager (PBM), and Personify Health®, the company making healthier easier, today announced a strategic partnership to offer employers a more personalized, clinically grounded approach to GLP-1 medication management and weight care. Through the partnership, LucyRx and Personify Health will deliver an integrated solution that combines pharmacy benefit strategy with personalized support fro...

DUBLIN--(BUSINESS WIRE)--The "Protein Drugs Market 2025" report has been added to ResearchAndMarkets.com's offering. The Protein Drugs Market was valued at USD 441.7 Billion in 2024, and is projected to reach USD 655.7 Billion by 2029, rising at a CAGR of 8.2% The report analyzes trends in the global market for protein drugs and manufacturing technologies. The report includes global revenue ($ millions) for the base year of 2023 and estimated data for the forecast period of 2024 through 2029. T...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's future dual glucose-ketone sensor with Tandem's innovative insulin delivery systems to provide more options for people to manage their diabetes. The Abbott sensor, currently under development, will combine glucose and ketone sensing technology that aims to h...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System. With this latest integration, the Omnipod 5 Automated Insulin Delivery (AID) System combines the benefits of tubeless AID and Dexcom’s latest diabetes management technology, all conveniently controlled from an iPhone. "This integration re...

NORTH CHICAGO, Ill.--(BUSINESS WIRE)--32 Biosciences, a leader in the field of gut microbiome medicine, today announced it has received $6 million in funding to support the continued development of its lead assets. The funding comes as the company prepares for a future Series A fundraise and advances toward key regulatory milestones. 32 Biosciences’ diagnostic platform technology quantitatively evaluates the gut microbiome’s functional health, assessing its ability to support key bodily functio...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Fable Therapeutics, a discovery-stage biotechnology company developing purpose-built biologics powered by state-of-the-art structure and sequence-based protein language models, today announced the appointment of David J. Baker, PhD, as Chief Scientific Officer (CSO). “David’s extensive experience in drug discovery, with a strong track record of high performance and scientific leadership across the cardio-metabolic therapeutic area, makes him an ideal leader to...

DUBLIN--(BUSINESS WIRE)--The "UAE Insulin Pumps Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to ResearchAndMarkets.com's offering. The UAE Insulin Pumps Market was valued at USD 64.35 Million in 2024 and is expected to reach USD 135.34 Million by 2030, rising at a CAGR of 13.15%. This market is gaining prominence as part of the country's expanding diabetes care framework, driven by a rising prevalence of Type 1 and insulin-dependent Type 2 diabetes. T...

SAN FRANCISCO--(BUSINESS WIRE)--Omada Health Announces Pricing of Initial Public Offering...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered digital health innovation, today announced it will power the newly launched Lilly Health™ Personalized Health & Medicine Platform* (Lilly Health app) with its cardiometabolic digital health platform. The Lilly Health app is designed to support a tailored patient experience for individuals interested in or using Eli Lilly and Company’s incretin-based therapies, for the treatment of cardiometabolic conditions, such as obesity, t...